Go to main content
Tricals - The highway towards a cure

Search

Results

page
Trials
Clinical trials are needed to find a cure for ALS. TRICALS supports multiple clinical trials. View the clinical trial overview to see current and past trials.
page
Our Services
Find below the range of services which TRICALS can support for companies.
news
European Commission approves Tofersen as treatment for ALS-SOD1

The European Commission has approved the drug QALSODY, better known as Tofersen. This means the drug will be allowed on the European market.

page
About TRICALS
TRICALS is the largest European research initiative to find a cure for ALS. We are a network of over 60 top research centres in more than 19 countries. Our one goal is to find effective treatments for people living with ALS.
events
TRICALS Masterclass 2025

The TRICALS Masterclass is an informal meeting with a maximum of 150 participants: consisting of researchers, industry, patient (representatives) and regulators.

page
Events
See all the important events and meeting for our TRICALS community. Curious to see who of the TRICALS office will be present at the event/meeting?
page
For companies
TRICALS partners with pharmaceutical and biotech companies to find a cure for ALS
page
TRICALS Academy
The TRICALS Academy is a platform that offers certified training for staff involved in ALS clinical trials.
page
Contact patients
page
Our team
TRICALS is a network lead by its members. The TRICALS team consists of an executive board, which is supported by the TRICALS operational office.
page
Precision ALS
Precision ALS is a collaborative programme which brings together experts from a wide range of disciplines from Clinicians to Data Scientists and more.
page
INARC
The International Network for ALS Research and Care (INARC) is a network of nurses, study coordinators and other professionals involved in ALS clinical research or care. The aim of the network is to connect members and to create a platform to exchange skills and expertise.